Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Huddart

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Clinical and Translational Radiation Oncology|July 3, 2025
Evaluation of therapeutic radiographer target volume contouring for magnetic resonance image guided online adaptive bladder radiotherapyBethany Williams, Jonathan Mohajer, Sophie E Alexander, et al.
Cancer Research|September 17, 2005
Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adultsAlan McIntyre, Brenda Summersgill, Beata Grygalewicz, et al.
Research Involvement and Engagement|July 2, 2025
Patient and public involvement in the SPRUCE methodology study investigating electronic patient reported outcomes in oncology clinical trialsMorgaine Stiles, Monisha Dewan, Georgina Manning, et al.
Oncogene|January 13, 2004
Amplification and overexpression of E2F3 in human bladder cancerAndrew Feber, Jeremy Clark, Graham Goodwin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 14, 2021
Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional StudyShirin ArdeshirRouhaniFard, Paul C Dinh, Patrick O Monahan, et al.
European Urology|October 4, 2018
BOXIT-A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004)John D Kelly, Wei Shen Tan, Nuria Porta, et al.
Cardio-Oncology (London, England)|November 24, 2022
The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunctionMaria Sol Andres, Sivatharshini Ramalingam, Stuart D Rosen, et al.
European Urology Oncology|April 16, 2025
Challenges in Defining Clinical Complete Response to Systemic Therapy in Muscle-invasive Bladder Cancer: Insights from the EORTC STARBURST ProjectAlexandra Masson-Lecomte, Guillaume Grisay, Julien Van Damme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2021
Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE)Simon J Crabb, Sarah Danson, James W F Catto, et al.
Ear and Hearing|January 24, 2022
Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric AssessmentsShirin Ardeshirrouhanifard, Sophie D Fossa, Robert Huddart, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Clinical and Translational Radiation Oncology|July 3, 2025
Evaluation of therapeutic radiographer target volume contouring for magnetic resonance image guided online adaptive bladder radiotherapyBethany Williams, Jonathan Mohajer, Sophie E Alexander, et al.
Cancer Research|September 17, 2005
Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adultsAlan McIntyre, Brenda Summersgill, Beata Grygalewicz, et al.
Research Involvement and Engagement|July 2, 2025
Patient and public involvement in the SPRUCE methodology study investigating electronic patient reported outcomes in oncology clinical trialsMorgaine Stiles, Monisha Dewan, Georgina Manning, et al.
Oncogene|January 13, 2004
Amplification and overexpression of E2F3 in human bladder cancerAndrew Feber, Jeremy Clark, Graham Goodwin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 14, 2021
Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional StudyShirin ArdeshirRouhaniFard, Paul C Dinh, Patrick O Monahan, et al.
European Urology|October 4, 2018
BOXIT-A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004)John D Kelly, Wei Shen Tan, Nuria Porta, et al.
Cardio-Oncology (London, England)|November 24, 2022
The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunctionMaria Sol Andres, Sivatharshini Ramalingam, Stuart D Rosen, et al.
European Urology Oncology|April 16, 2025
Challenges in Defining Clinical Complete Response to Systemic Therapy in Muscle-invasive Bladder Cancer: Insights from the EORTC STARBURST ProjectAlexandra Masson-Lecomte, Guillaume Grisay, Julien Van Damme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2021
Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE)Simon J Crabb, Sarah Danson, James W F Catto, et al.
Ear and Hearing|January 24, 2022
Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric AssessmentsShirin Ardeshirrouhanifard, Sophie D Fossa, Robert Huddart, et al.
Pageof 12